130 related articles for article (PubMed ID: 25254086)
1. Epidemiological and clinical characteristics of neuroblastoma in southern iran.
Bordbar M; Tasbihi M; Kamfiroozi R; Haghpanah S
Iran J Ped Hematol Oncol; 2014; 4(3):89-96. PubMed ID: 25254086
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical characteristics of children with peripheral neuroblastic tumors: a study on a Moroccan population.
Anissi Eddaibouni A; Bennani Guebessi N; Cherkaoui S; Karkouri M; Khoubila N; Maataoui-Belabbes H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18023-18027. PubMed ID: 37979055
[TBL] [Abstract][Full Text] [Related]
3. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
[No Abstract] [Full Text] [Related]
4. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
5. The development and initial evaluation of referral flowchart for suspected neuroblastoma for pediatricians in nononcology clinics in China.
Ma X; Duan C; Cai S; Wang X; Jiang C; Yue Z; Li K; Jin M; Zhang D; Wang X; Peng X
Pediatr Blood Cancer; 2021 May; 68(5):e28869. PubMed ID: 33381885
[TBL] [Abstract][Full Text] [Related]
6. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF CHILDREN WITH NEUROBLASTOMA: 21 YEARS OF EXPERIENCE AT THE INSTITUTO DE ONCOLOGIA PEDIÁTRICA, IN SÃO PAULO, BRAZIL.
Lucena JN; Alves MTS; Abib SCV; Souza GO; Neves RPC; Caran EMM
Rev Paul Pediatr; 2018; 36(3):254-260. PubMed ID: 29995142
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma Among Omani Children: Clinical characteristics and survival outcome from a dedicated centre.
Al-Battashi A; Al-Rahbi A; Al-Rawahi A; Mamdouh M; Al-Ghaithi I; Ramadhan FA
Sultan Qaboos Univ Med J; 2021 Nov; 21(4):578-584. PubMed ID: 34888077
[TBL] [Abstract][Full Text] [Related]
8. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
Vo KT; Matthay KK; Neuhaus J; London WB; Hero B; Ambros PF; Nakagawara A; Miniati D; Wheeler K; Pearson AD; Cohn SL; DuBois SG
J Clin Oncol; 2014 Oct; 32(28):3169-76. PubMed ID: 25154816
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
[No Abstract] [Full Text] [Related]
10. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
[TBL] [Abstract][Full Text] [Related]
11. Real World Experience of Treating Neuroblastoma: Experience from a Tertiary Cancer Centre in India.
Radhakrishnan V; Raja A; Dhanushkodi M; Ganesan TS; Selvaluxmy G; Sagar TG
Indian J Pediatr; 2019 May; 86(5):417-426. PubMed ID: 30778950
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma in Iran: an experience of 32 years at a referral childrens hospital.
Mehdiabadi GB; Arab E; Rafsanjani KA; Ansari S; Moinzadeh AM
Asian Pac J Cancer Prev; 2013; 14(5):2739-42. PubMed ID: 23803024
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of programmed cell death ligand-1 in neuroblastoma tissues].
Liao R; Sun XF; Zhen ZZ; Huang DS
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):735-740. PubMed ID: 30293276
[No Abstract] [Full Text] [Related]
14. Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004-2013.
Chen S; Tang W; Yang R; Hu X; Li Z
Am Surg; 2020 Feb; 86(2):127-133. PubMed ID: 32167055
[TBL] [Abstract][Full Text] [Related]
15. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
Cotterill SJ; Pearson AD; Pritchard J; Foot AB; Roald B; Kohler JA; Imeson J
Eur J Cancer; 2000 May; 36(7):901-8. PubMed ID: 10785596
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic survey of infantile cancer in Iran based on the data of the largest pediatric cancer referral center (Ali- Asghar Children Hospital), 1996-2005.
Bahoush-Mehdiabadi G; Habibi R; Shariftabrizi A; Vossough P
Asian Pac J Cancer Prev; 2014; 15(3):1211-7. PubMed ID: 24606443
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival and its related factors in pediatric liver transplant recipients of shiraz transplant center, shiraz, iran in 2012.
Haseli N; Hassanzadeh J; Dehghani SM; Bahador A; Malek Hosseini SA
Hepat Mon; 2013; 13(7):e10257. PubMed ID: 24065996
[TBL] [Abstract][Full Text] [Related]
20. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
